Biophytis (XPAR:ALBPS) Long-Term Debt : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biophytis Long-Term Debt?

Biophytis's Long-Term Debt for the quarter that ended in Jun. 2024 was €0.00 Mil.

Biophytis's quarterly Long-Term Debt declined from Jun. 2023 (€3.00 Mil) to Dec. 2023 (€2.43 Mil) and declined from Dec. 2023 (€2.43 Mil) to Jun. 2024 (€0.00 Mil).

Biophytis's annual Long-Term Debt declined from Dec. 2021 (€4.39 Mil) to Dec. 2022 (€3.51 Mil) and declined from Dec. 2022 (€3.51 Mil) to Dec. 2023 (€2.43 Mil).

Biophytis Long-Term Debt Historical Data

The historical data trend for Biophytis's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Long-Term Debt Chart

Biophytis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

4.39

0.94

4.39

3.51

2.43

Biophytis Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Debt	Get a 7-Day Free Trial															3.98	3.51	3.00	2.43	-

Biophytis (XPAR:ALBPS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biophytis Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biophytis's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biophytis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (XPAR:ALBPS) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BPTSY:USA 0D1W:UK 6XB3:Germany

Address

BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005

Website

https://www.biophytis.com

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Biophytis Headlines

No Headlines